Concepedia

Lukas Ronner

LR

Statistics

Publications

8

Citations

461

H-Index

8

Active since

2014

Affiliations

Icahn School of Medicine at Mount Sinai(Current)

University of Pennsylvania

Fox Chase Cancer Center

Yale University

New Mexico Cancer Center

Lukas Ronner is an author at Icahn School of Medicine at Mount Sinai specializing in oncology, medicine, and pharmacology.

ORCID

Publications per year

2014–2022

8

Publications

8

CTLA-4 Blockade Synergizes Therapeutically with PARP Inhibition in BRCA1-Deficient Ovarian Cancer

Tomoe Higuchi, Dallas B. Flies, Nicole A. Marjon et al. · Cancer Immunology Research · 2015 · 283 citations · Full text

, , +17

Persistent leukocytosis in polycythemia vera is associated with disease evolution but not thrombosis

Lukas Ronner, Nikolai A. Podoltsev, Jason Gotlib et al. · Blood · 2020 · 82 citations · Full text

, , +6

European LeukemiaNet Response Predicts Disease Progression but Not Thrombosis in Polycythemia Vera

Douglas Tremblay, Andrew Srisuwananukorn, Lukas Ronner et al. · HemaSphere · 2022 · 20 citations · Full text

, , +12

The immunomodulatory effects of pegylated liposomal doxorubicin are amplified in BRCA1− deficient ovarian tumors and can be exploited to improve treatment response in a mouse model

Gina Mantia-Smaldone, Lukas Ronner, Anne Blair et al. · Gynecologic Oncology · 2014 · 19 citations

, , +17

Plasma and cerebrospinal fluid pharmacokinetics of select chemotherapeutic agents following intranasal delivery in a non-human primate model

James C. League-Pascual, Cynthia M. Lester-McCully, Shaefali Shandilya et al. · Journal of Neuro-Oncology · 2017 · 17 citations · Full text

, , +15

1–5 of 8